Overview

Aims and Scope

Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including:

Cellular and molecular immunology; clinical immunology; allergy; immunochemistry; immunogenetics; immune signalling; immune development; imaging; mathematical modelling; autoimmunity; transplantation immunology; cancer immunology; Infection and infection models, virology, parasitology, microbiology; and Inflammation and inflammation models.

Our philosophy is that all sound data and evidence-driven immunology research has value and should be published and shared with the community therefore manuscripts within the scope of the journal will be evaluated for publication on the bases of;

• scientific rigor
• evidence that the data support conclusions
• adherence to technical and ethical standards

Immunity, Inflammation and Disease publishes original research articles, reviews, editorials, commentaries, registered reports and letters. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.

In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.

Open Access and Copyright
Immunity, Inflammation and Disease is a Wiley Open Access journal, one of a series of peer-reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website.

All articles published by Immunity, Inflammation and Disease are fully open access: immediately freely available to read, download and share. Articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Copyright on any research article in a journal published by Immunity, Inflammation and Disease is retained by the author(s). Authors grant Wiley a licence to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found here.

Peer review policy
Immunity, Inflammation and Disease maintains the highest standards of peer review while increasing the efficiency of the process. All research articles published in the journal undergo full peer review, key characteristics of which are:

• All research articles are initially evaluated by the Editor-in-Chief; articles found appropriate for the journal will be reviewed by at least two suitably qualified experts.
  • All publication decisions are made by the Editor-in-Chief on the basis of the reviews provided.
  • Members of the editorial boards lend insight, advice and guidance to the editors and assist in decision making on specific submissions.
  • The internal managing editor and editorial assistant provide administrative support to ensure Immunity, Inflammation and Diseasemaintains the integrity of peer review and delivers rapid and efficient publication to authors and reviewers.

Abstracting and Indexing Information

• CAS: Chemical Abstracts Service (ACS)
• Current Contents: Life Sciences (Clarivate Analytics)
• MEDLINE/PubMed (NLM)
• Science Citation Index Expanded (Clarivate Analytics)
• SCOPUS (Elsevier)
• Web of Science (Clarivate Analytics)